A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications
NCT07142980
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors Harboring RAS Mutations or Amplifications
Interventions
DRUG:
HRS-7172 Tablets
Sponsor
Jiangsu HengRui Medicine Co., Ltd.